Skip to content

Comparing Collared and Collarless Femoral Stems in Primary Total Hip Arthroplasty

Comparing Collared and Collarless Femoral Stems in Total Hip Arthroplasty

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07337642
Enrollment
100
Registered
2026-01-13
Start date
2025-12-03
Completion date
2027-12-31
Last updated
2026-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary Total Hip Arthroplasty

Brief summary

This is a prospective randomized control trial comparing two collared and collarless femoral implants used in primary total hip arthroplasty. The specific aims of this trial are to: SA1: Prospectively assess clinical outcomes in patients undergoing primary total hip arthroplasty with a collared versus collarless femoral stem of the same design. SA2: Evaluate serial radiographs to quantify differences in subsidence between collared and collarless implant groups. SA3: Report and compare incidence rates of intraoperative and postoperative periprosthetic fractures and aseptic loosening following primary total hip arthroplasty with use of either a collared or collarless stem. Hypothesis: The addition of a collar to the same designed triple-taper primary hip stem will lead to a reduction in subsidence and incidence of perioperative and periprosthetic femur fractures.

Interventions

OTHERCollarless Femoral Stem

Patients will be randomized to one of two groups receiving either a collarless or collared femoral stem. Patients randomized to this group will receive a collarless femoral stem implant at time of surgery.

OTHERCollared Femoral Stem

Patients will be randomized to one of two groups receiving either a collarless or collared femoral stem. Patients randomized to this group will receive a collared femoral stem at the time of surgery.

Sponsors

Medstar Health Research Institute
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 99 Years
Healthy volunteers
No

Inclusion criteria

* Adults (≥ 18 years old) scheduled for primary, uncemented THA using a cementless femoral stem * Diagnosis of primary osteoarthritis or other non-inflammatory degenerative joint disease. * Ability and willingness to comply with study procedures and follow-up schedule. * Ability to provide written informed consent

Exclusion criteria

* Patients not indicated for a cementless THA * Prior surgery on the ipsilateral hip (e.g., prior THA, internal fixation, osteotomy) * Use of cemented or hybrid femoral components. * Revision THA or conversion THA * Active or prior infection of the hip joint. * Severe osteoporosis (T-score ≤ -2.5) or known metabolic bone disease. * Inability to complete follow-up or anticipated relocation out of the area.

Design outcomes

Primary

MeasureTime frameDescription
Measurement of femoral stem subsidence at 6 weeks, 6 months, and 1-year post-operation6 weeks, 6 months, and 1 year post operationMeasurement of femoral stem subsidence at 6 weeks, 6 months, and 1-year post-operation used radiographic evidence.

Countries

United States

Contacts

Primary ContactMiles Hollimon, B.S.
miles.hollimon@medstar.net(202) 444-8766

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026